STRIDES PHARMA SCIENCE LIMITED — M&A Activity 2020

Jun 19, 2020

June 19, 2020

To, BSE Limited The National Stock Exchange of India Phiroze Jeejeebhoy Towers Limited Dalal Street, Mumbai – 400 001 Exchange Plaza, Bandra Kurla Complex, BSE Scrip code: 532531 Bandra (E), Mumbai – 400 051 NSE Scrip Code: STAR

Dear Sirs,

Sub: Order of the National Company Law Tribunal, Bengaluru Bench sanctioning merger of wholly owned subsidiaries

This has reference to our earlier communication of July 29, 2019 relating to merger of Arrow Remedies Private Limited (“Arrow Remedies”), Fagris Medica Private Limited (“Fagris Medica”) and Strides Emerging Markets Limited (“SEML”) with the Company, which are direct/ indirect wholly-owned subsidiaries of the Company.

We wish to inform that we have recently received the Order of the Bengaluru Bench of the National Company Law Tribunal, dated 28[th] May, 2020 (“Order”), which has sanctioned the petition filed by Strides Emerging Markets Limited for approval of the Scheme of Amalgamation of Arrow Remedies, Fagris Medica, SEML with Strides Pharma Science Limited (“SPSL”) and their respective shareholders and creditors (“Scheme”) pursuant to the provisions of Sections 230-232 and other applicable provisions of the Companies Act, 2013 (“the Act”).

The Appointed Date for the merger is April 1, 2019.

A joint petition for approval of the Scheme has been filed before the Mumbai Bench of the NCLT, since the registered offices of Arrow, Fagris and the Transferee Company are situated in Mumbai, Maharashtra.

Strides Pharma Science Limited (Formerly Strides Shasun Limited) CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 info@strides.com; www.strides.com

It may please be noted that though the Bengaluru Bench of the NCLT has approved the Scheme, the approval from the Mumbai Bench of the NCLT is still pending and hence, the Scheme would be effective once it is approved by the Mumbai Bench of the NCLT and necessary post approval actions are completed in accordance with the Scheme and orders passed by the Bengaluru and the Mumbai Bench of the NCLT.

You are requested to take the same on record.

Thanks & Regards,

For Strides Pharma Science Limited

==> picture [136 x 56] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [90 x 88] intentionally omitted <==

Strides Pharma Science Limited (Formerly Strides Shasun Limited) CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 info@strides.com; www.strides.com